Motoaki Seki

10PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Industrial biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 16, 2026
Repression of ROBO1 Enhances Cisplatin Sensitivity in Hypermethylated Subtype of HPV-Positive Head and Neck Carcinoma.

|Oct 09, 2025
DNA-hypermethylated human gastric cancer circumvents apoptosis in the absence of TP53 mutation.

Yasunobu Mano, Keisuke Matsusaka, Motoaki Seki

|May 21, 2025
A multi-kingdom genetic barcoding system for precise clone isolation.

Soh Ishiguro, Kana Ishida, Rina C Sakata

|Apr 21, 2023
Association of frequent hypermethylation with high grade histological subtype in lung adenocarcinoma.

Yuki Ito, Genki Usui, Motoaki Seki

|Jun 21, 2022
Association of tumors having Epstein-Barr virus in surrounding lymphocytes with poor prognosis.

Norikazu Yogi, Genki Usui, Keisuke Matsusaka

|Feb 09, 2022
Barcode fusion genetics-protein-fragment complementation assay (BFG-PCA): tools and resources that expand the potential for binary protein interaction discovery.

Daniel Evans-Yamamoto, François D Rouleau, Piyush Nanda

Pageof 2

Frequent Collaborators

6 joint publications

Nozomu Yachie

4 joint publications

Atsushi Kaneda

4 joint publications

Hideto Mori

4 joint publications

Hiroyuki Aburatani